NCT02893709View on ClinicalTrials.gov

Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG

Omeprazole

Oral administration of omeprazole at therapeutic dose (20 mg daily) for a duration of 7 days

Trial Locations (1)

529889

Changi General Hospital, Singapore

All Listed Sponsors
collaborator

National University of Singapore

OTHER

collaborator

Universiti Teknologi Mara

OTHER

lead

Changi General Hospital

OTHER

NCT02893709 - Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES) | Biotech Hunter | Biotech Hunter